Demonstration of cortical recording using novel flexible polymer neural probes (2008)
Mercanzini, André, Cheung, Karen, Buhl, D. L., Boers, M., Maillard, A., Colin, P., ...
We present the fabrication, characterization, use in cortical recording and histological results of a flexible implantable neural probe. The microfabricated device is implemented in polyimide and...
Lukas, C., Sharp, J.T., Angwin, J., Boers, M., Duryea, J., Hall, J.R., ...
Objective. Comparison of performances of 5 (semi)automated methods in measuring joint space width (JSW) in rheumatoid arthritis. Methods. Change in JSW was determined by 5 measurement methods on 4...
Plass, A. M. C., Lems, W. F., Voskuyl, A. E., Dijkmans, B. A. C., ...
Objective. The COBRA therapy (combination therapy in early rheumatoid arthritis) has proven to be an effective treatment for early RA, but is rarely prescribed. A survey showed reluctance of Dutch...
Jacobs, J Wg, Boers, M, Boumpas, D, Buttgereit, F, Caeyers, N, ...
OBJECTIVE: To develop evidence based recommendations for the management of systemic glucocorticoid (GC) therapy in rheumatic diseases. METHODS: The multidisciplinary guideline development group from...
Birol, H, Maeder, T, Nadzeyka, I, Boers, M, Ryser, P
This study is aimed at outlining the fabrication of a novel piezoresistive force sensor using LTCC technology, which operates at millinewton range, yet is compatible with low cost thick-film...
Lassere, M. N., Johnson, K. R., Boers, M., Tugwell, P., Brooks, P., Simon, L., ...
Objective. There are clear advantages to using biomarkers and surrogate endpoints, but concerns about clinical and statistical validity and systematic methods to evaluate these aspects hinder their...
Lassere, M. N., Johnson, K. R., Boers, M., Tugwell, P., Brooks, P., Simon, L., ...
Objective. There are clear advantages to using biomarkers and surrogate endpoints, but concerns about clinical and statistical validity and systematic methods to evaluate these aspects hinder their...
Sharp, J.T., Angwin, J., Boers, M., Duryea, J., Von Ingersleben, G., Hall, J.R., ...
Computer-based methods of measuring joint space width (JSW) could potentially have advantages over scoring joint space narrowing, with regard to increased standardization, sensitivity, and...
Birol, H., Maeder, T., Jacq, C., Corradini, G., Boers, M., Strässler, S., ...
The purpose of this paper is to demonstrate sensors and structures fabricated using the LTCC technology, which has been addressed and employed increasingly as a smart packaging approach for several...
Patient-reported pain is central to OMERACT rheumatology core measurement sets (2006)
Robinson, V, Boers, M, Brooks, P, Francis, D, Judd, M, McGowan, J, ...
This article provides evidence from the OMER-ACT (Outcome Measures in RheumAtology Clinical Trials) consensus conferences on patient-reported pain as a key outcome measure for most rheumatologic...
Patient-reported pain is central to OMERACT rheumatology core measurement sets (2006)
Robinson, V., Boers, M., Brooks, P., Francis, D., Judd, M., McGowan, J., ...
This article provides evidence from the OMER-ACT (Outcome Measures in RheumAtology Clinical Trials) consensus conferences on patient-reported pain as a key outcome measure for most rheumatologic...
Birol, H., Maeder, T., Boers, M., Jacq, C., Corradini, G., Ryser, P.
LTCC (low temperature co-fired ceramic) technology has recently gained a remarkable application potential in sensors field. This can be ascribed to many advantages it offers: the ease of LTCC tape...
Design and processing of low-range piezoresistive LTCC force sensors (2005)
Birol, H., Boers, M., Maeder, T., Corradini, G., Ryser, P.
Low-temperature cofired ceramic (LTCC) combines many advantageous features for low-range (force & pressure) piezoresistive sensors: ease of 3D structuration, availability of very thin sheets, low...
Milinewton force sensor based on low temperature co-fired ceramic (LTCC) technology (2005)
Birol, H., Maeder, T., Boers, M., Jacq, C., Corradini, G., Ryser, P.
Fabrication of a millinewton force sensor, which is based on LTCC technology as an alternative to the widely used alumina (Al2O3) is described. The new sensor, integrated with piezoresistor...
Lassere, M. N. D., Boers, M., Carlton, K., Day, R. O., De Wit, M., ...
A presentation, demonstration, and discussion of recently developed adverse event instruments were the topics for the OMERACT 7 Drug Safety Module. The module began with a plenary introducing the...
Minimal disease activity for rheumatoid arthritis: A preliminary definition (2005)
Wells, G. A., Boers, M., Shea, B., Brooks, P. M., Simon, L. S., Strand, C. V., ...
Agreement on response criteria in rheumatoid arthritis (RA) has allowed better standardization and interpretation of clinical trial reports. With recent advances in therapy, the proportion of...
Lassere, MND, Johnson, KR, Boers, M, Carlton, K, Day, RO, De Wit, M, ...
A presentation, demonstration, and discussion of recently developed adverse event instruments were the topics for the OMERACT 7 Drug Safety Module. The module began with a plenary introducing the...
Minimal disease activity for rheumatoid arthritis: A preliminary definition (2005)
Wells, G. A., Boers, M., Shea, B., Brooks, P. M., Simon, L. S., Strand, C. V., ...
Agreement on response criteria in rheumatoid arthritis (RA) has allowed better standardization and interpretation of clinical trial reports. With recent advances in therapy, the proportion of...
OMERACT: An international initiative to improve outcome measurement in rheumatology (2005)
Boers, M, Brooks, P, Simon, LS, Strand, V, Tugwell, P
OMERACT is the acronym for an international, informally organized network aimed at improving outcome measurement in rheumatology. Chaired by an executive committee it organizes consensus conferences...
Lassere, MND, Johnson, KR, Boers, M, Carlton, K, Day, RO, De Wit, M, ...
A presentation, demonstration, and discussion of recently developed adverse event instruments were the topics for the OMERACT 7 Drug Safety Module. The module began with a plenary introducing the...
Minimal disease activity for rheumatoid arthritis: A preliminary definition (2005)
Wells, G. A., Boers, M., Shea, B., Brooks, P. M., Simon, L. S., Strand, C. V., ...
Agreement on response criteria in rheumatoid arthritis (RA) has allowed better standardization and interpretation of clinical trial reports. With recent advances in therapy, the proportion of...
OMERACT: An international initiative to improve outcome measurement in rheumatology (2005)
Boers, M, Brooks, P, Simon, LS, Strand, V, Tugwell, P
OMERACT is the acronym for an international, informally organized network aimed at improving outcome measurement in rheumatology. Chaired by an executive committee it organizes consensus conferences...
Lassere, M. N. D., Johnson, Kent R., Boers, M., Carlton, K., Day, R. O., De Wit, M., ...
A presentation, demonstration, and discussion of recently developed adverse event instruments were the topics for the OMERACT 7 Drug Safety Module. The module began with a plenary introducing the...
Minimal disease activity for rheumatoid arthritis: a preliminary definition (2005)
Wells, G. A., Boers, M., Shea, B., Brooks, P. M., Simon, L. S., Strand, C. V., ...
Agreement on response criteria in rheumatoid arthritis (RA) has allowed better standardization and interpretation of clinical trial reports. With recent advances in therapy, the proportion of...
OMERACT 6: International consensus conference on outcome measures in Rheumatology (2003)
Brooks, P. M., Tugwell, P., Strand, C. V., Simon, L., Boers, M.
OMERACT 6: International consensus conference on outcome measures in Rheumatology (2003)
Brooks, P. M., Tugwell, P., Strand, C. V., Simon, L., Boers, M.
Boers, M, Vos, K, Visser, H, Hazes, J M W, ...
OBJECTIVE: The presence of certain HLA class II antigens is strongly associated with the progression of joint destruction in rheumatoid arthritis (RA). Such antigens may be more effective than other...
Welch, V, Singh, G, Strand, V, Fries, J, Boers, M, Ramey, D, ...
We describe the progress towards developing a patient rated toxicity index that meets all of the patient-important attributes defined by the OMERACT Drug Safety Working Party, These attributes are...
Welch, V, Singh, G, Strand, V, Fries, J, Boers, M, Ramey, D, ...
We describe the progress towards developing a patient rated toxicity index that meets all of the patient-important attributes defined by the OMERACT Drug Safety Working Party, These attributes are...
Verhoeven, A. C., Boers, M., Te Koppele, J. M., Van Der Laan, W. H., Markusse, H. M., Geusens, P., ...
Objectives. Exploration of bone metabolism changes at different levels of disease activity, both with and without oral corticosteroid therapy, and prediction of changes in joint damage and bone...
Recent developments for optimal end-points in rheumatoid arthritis clinical studies (2000)
Molenaar, ETM, Boers, M, Brooks, PM, Simon, L, Strand, V, Tugwell, P
Clinical studies in patients with rheumatoid arthritis (RA) provide valuable information on the course and outcome of the disease whereas clinical trials provide information on optimal treatment for...
Boers, M, Shea, B, Tugwell, P, Saurez-Almazor, M, ...
This is the initial report of the generic health OMERACT study concerned with the sensitivity to change of generic quality of life (QOL) measures. Our objective was to determine which QOL instrument...
Patient based methods for assessing adverse events in clinical trials (1999)
Gazarian, M., Tugwell, P., Boers, M., Bombardier, C., Brooks, P. M., Day, R., ...
Report of the OMERACT Task Force on Economic Evaluation (1999)
Gabriel, S., Tugwell, P., OBrien, B., Yelin, E., Drummond, M., Ruff, B., ...
Patient based methods for assessing adverse events in clinical trials (1999)
Gazarian, M., Tugwell, P., Boers, M., Bombardier, C., Brooks, P. M., Day, R., ...
Report of the OMERACT Task Force on Economic Evaluation (1999)
Gabriel, S., Tugwell, P., OBrien, B., Yelin, E., Drummond, M., Ruff, B., ...
Boonen, A., Boers, M., Kostense, P.
Objective. To determine the influence of reading series of films in chronological order, in pairs with unknown time sequence, or as single films, on precision and sensitivity to change. Methods. Two...
Dankert, T., Nieman, F., Rau, R., Boers, M.
Objective. To determine the reliability and sensitivity to change of a simplified radiological scoring method [simple erosion narrowing score (SENS)] for rheumatoid arthritis (RA). SENS was compared...
Boers, M, Verhoeven, A C, Markusse, H M, Van De Laar, M A, Westhovens, Rene; U0008450, Van Denderen, J C, ...
BACKGROUND: The value of intensive combination therapy in early rheumatoid arthritis is unproven. In a multicentre, double-blind, randomised trial (COBRA), we compared the combination of...
Simulation of a surf zone with a barred beach. Report 1. Wave heights and wave breaking (1996)
The present report describes some of the results obtained during experiments in the Large Wave Flume of the Fluid Mechanics Laboratory of the Delft University of Technology. The experiments are part...
Bedforms and undertow in the surf zone; an analysis of the LIP 11D-data (1995)
The present report gives the results of a study on bedforms and undertow in the surf zone. It is the objective of this study to get a better insight into the physical processes in the surf zone. In...
NO EFFECT OF MISOPROSTOL ON RENAL FUNCTION OF RHEUMATOID PATIENTS TREATED WITH DICLOFENAC (1991)
BOERS, M., DIJKMANS, B. A. C., BREEDVELD, F. C., CAMPS, J. A. J., CHANG, P. C., VAN BRUMMELEN, P., ...
Non-steroidal anti-inflammatory drugs can reversibly decrease renal function in patients with rheumatoid arthritis (RA). To test whether orally administered prostaglandins could mitigate this...
ERRORS IN THE PREDICTION OF CREATININE CLEARANCE IN PATIENTS WITH RHEUMATOID ARTHRITIS (1988)
BOERS, M., DIJKMANS, B. A. C., BREEDVELD, F. C., MATTIE, H.
The accuracy of two equations used to predict creatinine clearance was assessed in 27 patients with rheumatoid arthritis (RA) and 34 controls. Both equations were accurate in controls, but...
Klareskog, L, Boers, M, Landewe, R, Codreanu, C, Bolosiu, H, ...
Objective: To assess methods to calculate achieving and sustaining remission in a double blind randomised trial in patients with RA who received etanercept, methotrexate, or an...
Jacobs, J W G, Kirwan, J R, Boers, M, Saag, K G, Inês, L B S, ...
Adverse effects of glucocorticoids have been abundantly reported. Published reports on low dose glucocorticoid treatment show that few of the commonly held beliefs about their incidence, prevalence,...